Overall, the coordinated activity of these two incretin hormones supports metabolic balance by preventing both hyperglycaemia and hypoglycaemia, improving lipid profiles, and lowering cardiovascular risk in individuals with type 2 diabetes and obesity [3,4]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.